Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.48 |
| ▸ | GAA | P10253 | 3/20 | 0.47 |
| ▸ | KDM4E | B2RXH2 | 2/20 | 0.47 |
| ▸ | MAPK8 | P45983 | 1/20 | 0.46 |
| ▸ | KMT2A | Q03164 | 2/20 | 0.43 |
| ▸ | HDAC3 | O15379 | 2/20 | 0.42 |
| ▸ | HDAC1 | Q13547 | 2/20 | 0.42 |
| ▸ | HDAC2 | Q92769 | 2/20 | 0.42 |
| ▸ | HDAC10 | Q969S8 | 2/20 | 0.42 |
| ▸ | HDAC11 | Q96DB2 | 2/20 | 0.42 |
| ▸ | HDAC8 | Q9BY41 | 2/20 | 0.42 |
| ▸ | HDAC6 | Q9UBN7 | 2/20 | 0.42 |
| ▸ | NCOR2 | Q9Y618 | 1/20 | 0.42 |
| ▸ | GNAI3 | P08754 | 1/20 | 0.41 |
| ▸ | GNAO1 | P09471 | 1/20 | 0.41 |
| ▸ | GNAI1 | P63096 | 1/20 | 0.41 |
| ▸ | EPHX2 | P34913 | 2/20 | 0.39 |
| ▸ | TRPV1 | Q8NER1 | 4/20 | 0.38 |
| ▸ | CNR1 | P21554 | 2/20 | 0.38 |
| ▸ | CNR2 | P34972 | 2/20 | 0.38 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18329658 | 0.95 | SMN1; SMN2 (0.44) | SMN1; SMN2GAAKDM4EMAPK8KMT2A | |
| SCHEMBL4407502 | 0.94 | SMN1; SMN2 (0.43) | SMN1; SMN2GAAKDM4EMAPK8KMT2A | |
| SCHEMBL21236012 | 0.94 | GNAI3 (0.50) | SMN1; SMN2GAAKDM4EMAPK8KMT2A | |
| SCHEMBL8906309 | 0.92 | GNAI3 (0.52) | KMT2AGNAI3GNAO1GNAI1EPHX2 | |
| SCHEMBL4408312 | 0.92 | GNAI3 (0.52) | KMT2AGNAI3GNAO1GNAI1EPHX2 | |
| SCHEMBL23793654 | 0.92 | GNAI3 (0.52) | KMT2AGNAI3GNAO1GNAI1EPHX2 | |
| SCHEMBL271981 | 0.92 | GNAI3 (0.52) | KMT2AGNAI3GNAO1GNAI1EPHX2 | |
| SCHEMBL9403437 | 0.92 | GNAI3 (0.52) | KMT2AGNAI3GNAO1GNAI1EPHX2 | |
| SCHEMBL23783504 | 0.92 | GAA (0.45) | SMN1; SMN2GAAKDM4EMAPK8KMT2A | |
| SCHEMBL23793834 | 0.92 | GNAI3 (0.44) | SMN1; SMN2GAAKDM4EMAPK8KMT2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 394 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20260103650-A1 | THERMALLY STABLE COMPOSITIONS AND USE THEREOF AS ANTIFOULANTS | ECOLAB USA INC. (US) | 2026-04-16 | — | — | US | claimed |
| US-20180346834-A1 | COAL DUST TREATMENT METHODS AND COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2018-12-06 | — | — | US | claimed |
| EP-3303525-A2 | COAL DUST TREATMENT METHODS AND COMPOSITIONS | General Electric Company (US) | 2018-04-11 | — | — | EP | claimed |
| EP-2876099-B1 | Norbornadiene purification method | AIR LIQUIDE (FR) | 2017-11-15 | — | — | EP | claimed |
| WO-2016191019-A2 | COAL DUST TREATMENT METHODS AND COMPOSITIONS | GENERAL ELECTRIC COMPANY (US) | 2016-12-01 | — | — | WO | claimed |
| WO-2016166470-A1 | METHOD FOR DUAL PHOTOCHEMICAL/THERMAL CROSSLINKING ACTIVATABLE UNDER UV/VISIBLE IRRADIATION, AND COMPOSITION FOR IMPLEMENTING SAID METHOD | UNIVERSITÉ DE HAUTE-ALSACE (FR) | 2016-10-20 | — | — | WO | claimed |
| EP-2876098-B1 | Extractive distillation in a norbornadiene purification method | AIR LIQUIDE (FR) | 2016-07-13 | — | — | EP | claimed |
| WO-2015074875-A1 | NORBORNADIENE PURIFICATION METHOD | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2015-05-28 | — | — | WO | claimed |
| WO-2015074874-A1 | EXTRACTIVE DISTILLATION IN A NORBORNADIENE PURIFICATION METHOD | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2015-05-28 | — | — | WO | claimed |
| EP-2876099-A1 | Norbornadiene purification method | L'AIR LIQUIDE, SOCIETE ANONYME POUR L'ETUDE ET L'EXPLOITATION DES PROCEDES GEORGES CLAUDE (FR) | 2015-05-27 | — | — | EP | claimed |
| EP-0845448-A1 | Inhibiting polymerization of vinyl aromatic monomers | Ciba SC Holding AG (CH) | 1998-06-03 | — | — | EP | claimed |
| EP-0828195-A2 | Method for improving photoimage quality | Ciba SC Holding AG (CH) | 1998-03-11 | — | — | EP | claimed |
| US-5711767-A | AMINES, PHENOLIC COMPOUNDS AND NITROXIDE | CIBA SPECIALTY CHEMICALS CORPORATION (US) | 1998-01-27 | — | — | US | claimed |
| EP-0818526-A1 | Stabilizers for the prevention of gum formation in gasoline | Ciba SC Holding AG (CH) | 1998-01-14 | — | — | EP | claimed |
| EP-0794933-A1 | A METHOD FOR INHIBITING PREMATURE POLYMERIZATION OF VINYL AROMATIC MONOMERS | Ciba SC Holding AG (CH) | 1997-09-17 | — | — | EP | claimed |
| EP-0581737-B1 | Inhibiting polymerization of vinyl aromatic monomers | CIBA GEIGY AG (CH) | 1997-04-23 | — | — | EP | claimed |
| US-5545786-A | USING A STABLE HINDERED NITROXYL COMPOUND | CIBA-GEIGY CORPORATION (US) | 1996-08-13 | — | — | US | claimed |
| US-5545782-A | USING A STABLE HINDERED NITROXYL COMPOUND | CIBA-GEIGY CORPORATION (US) | 1996-08-13 | — | — | US | claimed |
| WO-1996016921-A1 | A METHOD FOR INHIBITING PREMATURE POLYMERIZATION OF VINYL AROMATIC MONOMERS | CIBA SPECIALTY CHEMICALS HOLDING INC. (CH) | 1996-06-06 | — | — | WO | claimed |
| EP-0581737-A2 | Inhibiting polymerization of vinyl aromatic monomers | CIBA-GEIGY AG (CH) | 1994-02-02 | — | — | EP | claimed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20260103650-A1 | THERMALLY STABLE COMPOSITIONS AND USE THEREOF AS ANTIFOULANTS | ADH1A, ADH5, ADH1C | SMN1; SMN2 3173/4885GAA 4307/4885KDM4E 3834/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.